89 related articles for article (PubMed ID: 22821904)
1. Role of microparticles as messengers enhancing stem cell activity after genetic engineering.
Liehn EA; Bucur O; Weber C
Circ Res; 2012 Jul; 111(3):265-7. PubMed ID: 22821904
[No Abstract] [Full Text] [Related]
2. Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction.
Mackie AR; Klyachko E; Thorne T; Schultz KM; Millay M; Ito A; Kamide CE; Liu T; Gupta R; Sahoo S; Misener S; Kishore R; Losordo DW
Circ Res; 2012 Jul; 111(3):312-21. PubMed ID: 22581926
[TBL] [Abstract][Full Text] [Related]
3. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.
Brenner W; Aicher A; Eckey T; Massoudi S; Zuhayra M; Koehl U; Heeschen C; Kampen WU; Zeiher AM; Dimmeler S; Henze E
J Nucl Med; 2004 Mar; 45(3):512-8. PubMed ID: 15001696
[TBL] [Abstract][Full Text] [Related]
4. Individuals appropriate for benefit of stem cell therapy in acute myocardial infarction.
Arslan Z; Aparci M; Tavlaşoğlu M
Int J Cardiol; 2013 Oct; 168(3):2911-2. PubMed ID: 23608400
[No Abstract] [Full Text] [Related]
5. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells.
Reiffers J; Cailliot C; Dazey B; Attal M; Caraux J; Boiron JM
Lancet; 1999 Sep; 354(9184):1092-3. PubMed ID: 10509503
[TBL] [Abstract][Full Text] [Related]
6. Stem cell therapy for the broken heart: mini-organ transplantation.
Mansour S; Roy DC; Lemieux B; Ouellet C; Stevens LM; Noiseux N
Transplant Proc; 2009 Oct; 41(8):3353-7. PubMed ID: 19857748
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction.
Iwasaki H; Kawamoto A; Ishikawa M; Oyamada A; Nakamori S; Nishimura H; Sadamoto K; Horii M; Matsumoto T; Murasawa S; Shibata T; Suehiro S; Asahara T
Circulation; 2006 Mar; 113(10):1311-25. PubMed ID: 16534028
[TBL] [Abstract][Full Text] [Related]
8. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection.
Blocklet D; Toungouz M; Berkenboom G; Lambermont M; Unger P; Preumont N; Stoupel E; Egrise D; Degaute JP; Goldman M; Goldman S
Stem Cells; 2006 Feb; 24(2):333-6. PubMed ID: 16223854
[TBL] [Abstract][Full Text] [Related]
9. Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction.
Archundia A; Aceves JL; López-Hernández M; Alvarado M; Rodriguez E; Díaz Quiroz G; Páez A; Rojas FM; Montaño LF
Life Sci; 2005 Dec; 78(3):279-83. PubMed ID: 16183081
[TBL] [Abstract][Full Text] [Related]
10. Highly efficient retroviral gene transfer into immortalized CD34(-) cells and organ distribution after transplantation into NOD/SCID mice.
Thalmeier K; Huss R
Cytotherapy; 2001; 3(4):245-51. PubMed ID: 12171712
[TBL] [Abstract][Full Text] [Related]
11. Optimal CD34(+) cell dose in autologous peripheral-blood stem-cell transplantation.
Sezer O; Possinger K; Metzner B; Illiger HJ; Wattad M; Heit W; Fuss H; Schultze W
J Clin Oncol; 2000 Sep; 18(18):3319-20. PubMed ID: 10986066
[No Abstract] [Full Text] [Related]
12. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G
Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376
[TBL] [Abstract][Full Text] [Related]
13. GFP-transduced CD34+ and Lin- CD34- hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct.
Norol F; Bonnet N; Peinnequin A; Chretien F; Legrand R; Isnard R; Herodin F; Baillou C; Delache B; Negre D; Klatzmann D; Vernant JP; Lemoine FM
Exp Hematol; 2007 Apr; 35(4):653-61. PubMed ID: 17379075
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow mononuclear cells labeled with Tc-99m hexamethylpropylene amine oxime scintigraphy after intracoronary stem cell therapy in acute myocardial infarction.
Mesquita CT; Correa PL; Felix RC; Azevedo JC; Alves S; Oliveira CC; Sousa AL; Borojevic R; Dohmann HF
J Nucl Cardiol; 2005; 12(5):610-2. PubMed ID: 16171723
[No Abstract] [Full Text] [Related]
15. [Indications and limitations of purified CD34-positive cell transplantation].
Kawano Y; Takagami Y
Rinsho Ketsueki; 1999 Jun; 40(6):459-63. PubMed ID: 10422278
[No Abstract] [Full Text] [Related]
16. Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.
Reisner Y; Gur H; Reich-Zeliger S; Martelli MF; Bachar-Lustig E
Ann N Y Acad Sci; 2005 Jun; 1044():70-83. PubMed ID: 15958699
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction.
Armiñán A; Gandía C; García-Verdugo JM; Lledó E; Trigueros C; Ruiz-Saurí A; Miñana MD; Solves P; Payá R; Montero JA; Sepúlveda P
J Am Coll Cardiol; 2010 May; 55(20):2244-53. PubMed ID: 20466205
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic transplantation of CD34+ cord blood stem cells into newborn and adult NOD/SCID mice induce differential organ engraftment.
Wulf-Goldenberg A; Keil M; Fichtner I; Eckert K
Tissue Cell; 2012 Apr; 44(2):80-6. PubMed ID: 22197619
[TBL] [Abstract][Full Text] [Related]
19. Immunologic aspects of hematopoietic stem-cell transplantation.
O'Reilly RJ
Cytotherapy; 2002; 4(5):431-2. PubMed ID: 12473213
[No Abstract] [Full Text] [Related]
20. Circulating human CD34+ progenitor cells modulate neovascularization and inflammation in a nude mouse model.
van der Strate BW; Popa ER; Schipper M; Brouwer LA; Hendriks M; Harmsen MC; van Luyn MJ
J Mol Cell Cardiol; 2007 Jun; 42(6):1086-97. PubMed ID: 17490680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
